The partners of the PGT consortium will attend the annual meeting of the European Society for Gene and Cell Therapy at Helsinki from 17-20 September 2015. Latest developments in vector production and characterization will be presented by the CHU Nantes and GENETHON.
Généthon veut trouver des fonds pour un investissement de 100 millions d’euros. « Construire une usine, capable de fabriquer les produits de thérapie génique à l’échelle industrielle nécessite un investissement de 100 millions d’euros » : pour Frédéric Revah, directeur général de Généthon, un tel investissement est hors de portée de sa structure. Financé grâce aux dons de l’AFM-Téléthon, … [Read more]
Tuesday April 28, during a ceremony at the Elysee Palace, Généthon, the laboratory of the AFM-Telethon, was named recipient of the Global Innovation Competition 2030 in the category “Risk lift.” A prize that rewards the expert laboratory and world leader in the field of gene therapy for the development of an industrial production process of gene therapy vectors. Read … [Read more]
Genethon will present different works at the ISBiotech 5th Spring meeting on March, that takes place in Washington DC, USA. More information
Genethon presented a work entitled “production of AAV vectors for gene therapie of rare diseases using insect cells » at Insectinov, in Romainville (France), on December, 2014. More information
Partners of the PGT consortium presented their work at Biogenouest, in Rennes (France), on November, 2014. Agenda Read more about Biogenouest
The PGT consortium will be present at the European congress of Gene and Cell therapy (ESGCT) in The Hague (Netherlands), October 23-26, 2014.
PGT partners have attended the Annual meeting of the American Society of Gene and Cell Therapy (ASGCT) that took place in Washington DC, USA, May 21-24. Both Genethon and CHU Nantes have presented new data on vector production and purification. CHU Nantes presented the work entitled “Scalable upstream and downstream process for AAVrh10 vectors produced … [Read more]
On the occasion of the first edition of the congress NETIB, “New & Emerging Trends in Biotechnology”, held on 9 and 10 May in Bordeaux, France, Genethon was invited to make a presentation entitled “Gene Therapy: Entering the Era of Industrial Manufacturing”. More information
Genethon presented a work entitled “Analytical methods to measure full and empty particles” at the ISBiotech 4th Spring meeting on March, that took place in Washington DC, USA. More information